Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies
Journal article published in 2020 by
Bradley Alexander McGregor 
,
Matthew T. Campbell,
Wanling Xie,
Subrina Farah,
Mehmet A. Bilen ,
Andrew L. Schmidt ,
Guru P. Sonpavde,
Kerry L. Kilbridge,
Atish D. Choudhury,
Amir Mortazavi,
Amishi Y. Shah,
Aradhana M. Venkatesan,
Glenn J. Bubley,
Arlene O. Siefker‐Radtke,
Rana R. McKay
and other authors.
,
Matthew T. Campbell,
Wanling Xie,
Subrina Farah,
Mehmet A. Bilen ,
Andrew L. Schmidt ,
Guru P. Sonpavde,
Kerry L. Kilbridge,
Atish D. Choudhury,
Amir Mortazavi,
Amishi Y. Shah,
Aradhana M. Venkatesan,
Glenn J. Bubley,
Arlene O. Siefker‐Radtke,
Rana R. McKay
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 